Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism

Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism

Bibliographic Details
Main Authors:	David B. Karpf, Sanchita Mourya, Aliya Khan, Lars Rejnmark
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S235218722030111X

Similar Items

Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism
by: Lars Rejnmark, et al.
Published: (2021-04-01)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
by: Carmina Teresa Fuss, et al.
Published: (2020-06-01)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
by: Hiroshi Noda, et al.
Published: (2020-07-01)

The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
by: Kennett Sprogøe, et al.
Published: (2017-10-01)

A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
by: Charlotte Höybye, et al.
Published: (2017-03-01)

Modeling of Oxidized PTH (oxPTH) and Non-oxidized PTH (n-oxPTH) Receptor Binding and Relationship of Oxidized to Non-Oxidized PTH in Children with Chronic Renal Failure, Adult Patients on Hemodialysis and Kidney Transplant Recipients
by: Berthold Hocher, et al.
Published: (2013-07-01)

Desperate Times Call for Desperate Measures: Use of Continuous Subcutaneous 1-34 PTH Infusion for Postsurgical Hypoparathyroidism
by: Adnan Haider, et al.
Published: (2021-01-01)

Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
by: Hesham Tawfeek, et al.
Published: (2010-08-01)

Project and team handler (PTH)
by: Alhabashneh, Mohammad Abad Alhameed
Published: (2006)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
by: Fabio Medas, et al.
Published: (2019-04-01)

Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
by: Forough Saki, et al.
Published: (2020-05-01)

Correlation between iPTH levels on the first postoperative day after total thyroidectomy and permanent hypoparathyroidism: our experience
by: Canu Gian Luigi, et al.
Published: (2019-06-01)

Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies
by: Pooja E. Mishra, et al.
Published: (2016-01-01)

Study of Dental Caries and PTH Gene
by: Caio Luiz Bitencourt Reis, et al.
Published: (2021-08-01)

Role of PTH in the Renal Handling of Phosphate
by: Rebecca D. Murray, et al.
Published: (2015-08-01)

Effects of PTH analogue on the Progression of Osteoarthritis
by: Hsin-Yi Lee, et al.
Published: (2009)

Decrease in the expression of the type 1 PTH/PTHrP receptor (PTH1R) on chondrocytes in animals with osteoarthritis
by: Skwara Adrian, et al.
Published: (2010-04-01)

Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34).
by: Yongxin Ren, et al.
Published: (2011-01-01)

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH
by: Kuragano Takahiro, et al.
Published: (2013-01-01)

Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
by: Domenico Umberto De Rose, et al.
Published: (2019-06-01)

Low PTH Levels in Adolescents With Anorexia Nervosa
by: Nina Lenherr-Taube, et al.
Published: (2020-03-01)

PTH Reloaded: A New Evolutionary Perspective
by: Paula Suarez-Bregua, et al.
Published: (2017-10-01)

The Effects of PTH Gene Therapy on Periodontal regeneration
by: Chia-Jen Yu, et al.
Published: (2008)

PTH Gene Polymorphism and Breast Cancer Risk in Kazakhstan
by: Nurgul Sikhayeva, et al.
Published: (2014-12-01)

Clinical and experimental studies on vitamin D and PTH metabolism
by: Osman, O. M.
Published: (1988)

HDAC4 Integrate PTH and Sympathetic Signaling In Osteoblasts
by: Makinistoglu, Munevver
Published: (2014)

HDAC4 Integrates PTH and Sympathetic Signaling in Osteoblasts
by: Makinistoglu, Munevver Parla
Published: (2014)

Adipose lipolysis is required for PTH-induced bone formation
by: Nathalie Alekos, et al.
Published: (2021-04-01)

Additive effect of Act-RIIA-mFc and PTH in the prevention of disuse-induced bone loss
by: Mikkel Bo Brent, et al.
Published: (2020-10-01)

POS-551 INTRAOPERATIVE PLASMA (1-84) PTH LEVELS ARE BETTER THAN INTACT PTH FOR ASSESSING THE SUCCESS OF PARATHYROIDECTOMY IN UREMIC HYPERPARATHYROIDISM PATIENTS
by: F. Xu, et al.
Published: (2021-04-01)

PTH-rP and PTH-R1 Expression in Placentas from Pregnancies Complicated by Gestational Diabetes: New Insights into the Pathophysiology of Hyperglycemia in Pregnancy
by: Angelo Sirico, et al.
Published: (2021-07-01)

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone
by: Lars Rejnmark, et al.
Published: (2015-12-01)

Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone
by: Lars Rejnmark, et al.
Published: (2014-01-01)

Effect of PTH and corticotomy on implant movement under mechanical force
by: Jiyeon Kim, et al.
Published: (2020-11-01)

Increased PTH maintains bone mineral density in patients with CKD
by: Pierre-Emmanuel Cailleaux, et al.
Published: (2020-10-01)

Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37
by: Wolf-Georg Forssmann, et al.
Published: (2016-08-01)

Serum PTH levels in dialysis: better safe than sorry
by: Mario Cozzolino, et al.
Published: (2020-12-01)

Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
by: Shilpa Choudhary, et al.
Published: (2015-01-01)

FEM analysis of the tridimensionnel effect of microvoids on the PMMA behaviour in PTH.
by: Leila ZOUAMBI, et al.
Published: (2018-06-01)

Control of bone mass and remodeling by PTH receptor signaling in osteocytes.
by: Charles A O'Brien, et al.
Published: (2008-08-01)

Cannot write session to /tmp/vufind_sessions/sess_t4e7v2hfc4rb31ffuqsu9fca57